© by Dr. Hilmar Alquiros, The Philippines Impressum Datenschutzerklärung
Chilean study shows variations in success of COVID-19 vaccines:
By Aislinn Laing & Fabian Cambero (Aug.4th, 2021; Excerpts)
Chile began one of the world's fastest inoculation campaigns against COVID-19 in December, having now fully vaccinated > 60% of its population, predominantly with Sinovac's 'CoronaVac'.
Health official Dr. Rafael Araos in a press conference in August 2021: Sinovac (CoronaVac) 8.6 million people, Pfizer BioNTech 4.5 million, AstraZeneca 2.3 million (!!) >> trials...
|Effective in preventing:||Sinovac||BioNTech / Pfizer||AstraZeneca|
|"Developed in":||China||Germany*||Great Britain**|
|N (million people:)||8.6 m||4.5 m||2.3 m|
|Hospitalization / ICU / ICU||89.70%||98.00%||98.00%|
* Invented, developed by BioNTech, Mainz / Germany; also produced by Pfizer (USA).
** Oxford University + AstraZeneca = British-Swedish; Moderna's values similar to BioNTech, Johnson & Johnson's values similar to AstraZeneca!
Dr. Araos said a reduction in protection from vaccines was inevitable over time, particularly with the arrival and growing prevalence of more virulent strains such as the Delta variant:
"If Delta becomes more prevalent and the vaccine has a weaker response, we could observe a faster fall (in effectiveness)," he said, adding his voice to calls for a third, booster dose to be issued.
"Find the differences...!" Delta mutation wins the battle...in GB 99% of infections - → Evolution to observe directly! (h.a.)